Analysis reveals that prophylactic antiseizure medications do not improve outcomes in post-traumatic epilepsy, indicating a need for alternative strategies.
Post-traumatic epilepsy (PTE) is a significant sequela of traumatic brain injury (TBI), with a high incidence of drug-resistant epilepsy. The role of prophylactic antiseizure medications (ASM) remains controversial. This study investigates the demographic, clinical, radiological, and electrophysiological characteristics of PTE and evaluates the impact of ASM use.
No takes yet. Share an insight, caveat, or question.
Kizek et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: